Skip to content

The effect of the pilates method in the treatment of women with Fibromyalgia

Effectiveness of the pilates method in the treatment of women with Fibromyalgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6j3gnr7
Enrollment
Unknown
Registered
2021-05-27
Start date
2016-08-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

Sixty-six patients were randomized into two groups: Thirty-four patients for the pilates group and thirty-two for the control group Pilates Group patients underwent Pilates sessions, three times a wee
C05.651.324
E02.779.474
SP4.031.100.200.292.663.229

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female patients diagnosed with Fibromyalgia based on the 1990 criteria of the American College of Rheumatology, pain on the numerical scale of pain between 3 and 8 cm; age between 18 and 65 years and everyone should have agreed to participate in the research by signing the consent form.

Exclusion criteria

Exclusion criteria: Inflammatory rheumatic diseases; neurological diseases; patients who were undergoing psychiatric treatment; practice of physical activity started or changed in the last three months; medication started or changed in the last three months; patients with uncontrolled cardiorespiratory and cardiovascular diseases or any condition that contraindicates exercise; patients with uncontrolled diabetes mellitus and other musculoskeletal diseases that prevented the practice of the method.

Design outcomes

Primary

MeasureTime frame
Decrease in pain, verified by the numerical pain scale, from the observation of an improvement of at least 20% in the measurements over time.

Secondary

MeasureTime frame
Increase in quality of life, as verified by the Fibromyalgia Impact Questionnaire (FIQ), based on the observation of an improvement of at least 20% in the measurements over time.;Decrease in catastrophizing, verified by questionnaire of hair avoidance of the medium, from the improvement of at least 20% in the measurements over time.;Decrease in anxiety and depression, verified by Beck's depression inventory, from the observation of an improvement of at least 20% in the measurements over time.;Increase in the general quality of life, verified by the SF-36 questionnaire, from the observation of an improvement of at least 20% in the measurements over time.;Increase in functional capacity, verified by the six-minute walk test, from the observation of an improvement of at least 20% in the measurements over time.;Decrease in kinesiophobia, verified by the kinesiophobia scale, from the observation of an improvement of at least 20% in the measurements over time.;Increase in patient satisfaction with the treatment, verified by the Likert scale, from the observation of an improvement of at least 20% in the measurements over time. ;Decrease in the consumption of painkillers, verified by counting the number of painkillers consumed, from the observation of an improvement of at least 20% in the measurements over time.

Countries

Brazil

Contacts

Public ContactAnamaria Jones

Universidade Federal de São Paulo

anamaria.jones@unifesp.br+551155764848 - 2756

Outcome results

None listed

Source: REBEC (via WHO ICTRP)